Medicis is an independent pharmaceutical company focusing exclusively on the treatment of dermatological conditions. Medicis offers prescription, over-the-counter and physician-dispensed dermatology products, emphasizing the clinical effectiveness, quality, affordability and cosmetic elegance of its products. Medicis has achieved a leading position in branded products for the treatment of acne, acne-related conditions, psoriatic conditions and pruritic conditions, while also offering the leading over-the-counter topical analgesic and fade cream product in the U.S.
Industry:MED-DRUGS Sector: Medical Fiscal Year End:December Last Reported Quarter:03/31/12 Next EPS Date:08/06/12
Capital Structure Solvency and Cash Flow
The company generated cash flow from operations of about $21.2 million during 2Q10 versus $5.6 million during 2Q09. Cash flow within the period was primarily due to the company's strong profitability and changes in working capital.
The company ended 2Q10 with cash, cash equivalents and short- and long-term investments of about $605.0 million versus $553.8 million at the end of FY09.
Last edited Fri Nov 12, 2010 02:16 AM by PushpanjaliBanerjee (Zacks Investment Research)
Governance Social Responsibility and Employee Relations
